Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toxicity profile of the GATA-3-specific DNAzyme hgd40 after inhalation exposure.
Fuhst R, Runge F, Buschmann J, Ernst H, Praechter C, Hansen T, von Erichsen J, Turowska A, Hoymann HG, Müller M, Pohlmann G, Sewald K, Ziemann C, Schlüter G, Garn H. Fuhst R, et al. Among authors: muller m. Pulm Pharmacol Ther. 2013 Apr;26(2):281-9. doi: 10.1016/j.pupt.2012.12.005. Epub 2012 Dec 20. Pulm Pharmacol Ther. 2013. PMID: 23266273
Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge.
Mole S, Harry A, Fowler A, Hotee S, Warburton J, Waite S, Beerahee M, Behm DJ, Badorrek P, Müller M, Faulenbach C, Lazaar AL, Hohlfeld JM. Mole S, et al. Among authors: muller m. Pulm Pharmacol Ther. 2020 Oct;64:101977. doi: 10.1016/j.pupt.2020.101977. Epub 2020 Nov 13. Pulm Pharmacol Ther. 2020. PMID: 33189900 Clinical Trial.
Lung pharmacokinetics of inhaled and systemic drugs: A clinical evaluation.
Sadiq MW, Holz O, Ellinghusen BD, Faulenbach C, Müller M, Badorrek P, Eriksson UG, Fridén M, Stomilovic S, Lundqvist AJ, Hohlfeld JM. Sadiq MW, et al. Among authors: muller m. Br J Pharmacol. 2021 Nov;178(22):4440-4451. doi: 10.1111/bph.15621. Epub 2021 Aug 11. Br J Pharmacol. 2021. PMID: 34250588 Free article.
The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers.
Gress C, Vogel-Claussen J, Badorrek P, Müller M, Hohl K, Konietzke M, Litzenburger T, Seibold W, Gupta A, Hohlfeld JM. Gress C, et al. Among authors: muller m. Pulm Pharmacol Ther. 2023 Oct;82:102246. doi: 10.1016/j.pupt.2023.102246. Epub 2023 Aug 9. Pulm Pharmacol Ther. 2023. PMID: 37562641 Clinical Trial.
RLS-0071, a novel anti-inflammatory agent, significantly reduced inflammatory biomarkers in a randomised human evaluation of mechanisms and safety study.
Cunnion K, Goss J, Hair P, Dell L, Roberson D, Thienel U, Müller M, Carstensen-Aurèche S, Badorrek P, Holz O, Hohlfeld JM. Cunnion K, et al. Among authors: muller m. ERJ Open Res. 2024 Sep 16;10(4):01006-2023. doi: 10.1183/23120541.01006-2023. eCollection 2024 Jul. ERJ Open Res. 2024. PMID: 39286057 Free PMC article.
A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
Greulich T, Hohlfeld JM, Neuser P, Lueer K, Klemmer A, Schade-Brittinger C, Harnisch S, Garn H, Renz H, Homburg U, Renz J, Kirsten A, Pedersen F, Müller M, Vogelmeier CF, Watz H. Greulich T, et al. Among authors: muller m. Respir Res. 2018 Apr 4;19(1):55. doi: 10.1186/s12931-018-0751-x. Respir Res. 2018. PMID: 29615049 Free PMC article. Clinical Trial.
11,252 results
You have reached the last available page of results. Please see the User Guide for more information.